How much funding has Novoic raised?

Novoic has raised $2.6M in total funding, most recently a Seed round.

Where is Novoic headquartered?

Novoic is headquartered in United Kingdom.

Novoic

Q: Who are Novoic's investors?

Novoic's investors include Anthemis Exponential Ventures, APEX Capital, Entrepreneur First.

Earlier Alzheimer's detection anywhere in 10 minutes

United Kingdom · $2.6M raised

Insurtech

Employees: 11–50
Website: novoic.com
Total Funding: $2.6M

Last Round: $2.6M SeedJul 2020
Rounds: 1

About

Novoic is a London-based clinical digital health company developing AI-powered speech biomarker software for the early detection of Alzheimer's disease and cognitive impairment. Its flagship product, Novoic Storyteller, uses brief automated speech recordings analyzed by proprietary algorithms to detect subtle cognitive changes and predict amyloid positivity — validated through the AMYPRED clinical trials. The platform serves 50+ medical institutions across the US in partnership with the Alzheimer's Disease Neuroimaging Initiative (ADNI), enabling scalable, remote screening for underserved communities.

Summary

Novoic is an Insurtech company based in United Kingdom. It has raised $2.6M in total across 1 round, most recently a $2.6M Seed round in Jul 2020. Investors include Anthemis Exponential Ventures, APEX Capital and Entrepreneur First.